Mercer Global Advisors Portfolio holdings
AUM
$44.5B
1-Year Return
12.22%
This Quarter Return
+7.41%
1 Year Return
+12.22%
3 Year Return
+48.64%
5 Year Return
+80.05%
10 Year Return
–
AUM
$44.5B
AUM Growth
+$953M
(+2.2%)
Cap. Flow
-$1.95B
Cap. Flow
% of AUM
-4.37%
Top 10 Holdings %
Top 10 Hldgs %
42.29%
Holding
2,379
New
229
Increased
1,000
Reduced
942
Closed
161
Top Buys
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$211M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$200M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$192M |
| 4 |
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
|
$124M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$105M |
Top Sells
| 1 |
Apple
AAPL
|
$1.12B |
| 2 |
NVIDIA
NVDA
|
$544M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$380M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$251M |
| 5 |
Meta Platforms (Facebook)
META
|
$211M |
Sector Composition
| 1 | Technology | 4.56% |
| 2 | Financials | 4.15% |
| 3 | Consumer Discretionary | 2.85% |
| 4 | Healthcare | 2.32% |
| 5 | Industrials | 2.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Blend Labs
BLND
$947M
| $37.3K | ﹤0.01% |
+11,294
| New | +$37.3K |
|
2177
Black Diamond Therapeutics
BDTX
$163M
| $36K | ﹤0.01% |
+14,521
| New | +$36K |
|
|
DHF
2178
BNY Mellon High Yield Strategies Fund
DHF
$190M
| $34.6K | ﹤0.01% |
+13,307
| New | +$34.6K |
|
2179
Banco Bradesco
BBD
$32.5B
| $34.1K | ﹤0.01% |
11,031
-816
| -7% | -$2.52K |
|
2180
Genelux
GNLX
$131M
| $30.9K | ﹤0.01% |
10,750
| – | – |
|
|
CRDL
2181
Cardiol Therapeutics
CRDL
$92.9M
| $30.7K | ﹤0.01% |
+22,600
| New | +$30.7K |
|
2182
Milestone Pharmaceuticals
MIST
$151M
| $29.3K | ﹤0.01% |
+15,100
| New | +$29.3K |
|
2183
American Battery Technology Co
ABAT
$232M
| $27.8K | ﹤0.01% |
17,154
-12,197
| -42% | -$19.8K |
|
|
NXDR
2184
Nextdoor Holdings
NXDR
$794M
| $27.5K | ﹤0.01% |
+16,592
| New | +$27.5K |
|
2185
Lightwave Logic
LWLG
$391M
| $27.3K | ﹤0.01% |
22,008
-24
| -0.1% | -$30 |
|
2186
Open Lending Corp
LPRO
$267M
| $26.9K | ﹤0.01% |
+13,841
| New | +$26.9K |
|
2187
Ironwood Pharmaceuticals
IRWD
$179M
| $24K | ﹤0.01% |
+33,415
| New | +$24K |
|
2188
Research Frontiers
REFR
$43.7M
| $23K | ﹤0.01% |
14,000
| – | – |
|
2189
Cerus
CERS
$255M
| $21.6K | ﹤0.01% |
+15,314
| New | +$21.6K |
|
2190
8x8 Inc
EGHT
$269M
| $19.7K | ﹤0.01% |
+10,028
| New | +$19.7K |
|
2191
GrafTech
EAF
$239M
| $16.9K | ﹤0.01% |
+1,741
| New | +$16.9K |
|
2192
Nkarta
NKTX
$151M
| $16.7K | ﹤0.01% |
+10,082
| New | +$16.7K |
|
2193
PDS Biotechnology
PDSB
$56.9M
| $16.6K | ﹤0.01% |
12,510
+10
| +0.1% | +$13 |
|
2194
Oxbridge Re Holdings Limited Warrant expiring 3/26/2029
OXBRW
$2.98M
| $15.7K | ﹤0.01% |
47,500
| – | – |
|
2195
Pacific Biosciences
PACB
$372M
| $15.4K | ﹤0.01% |
12,387
-22,507
| -65% | -$27.9K |
|
2196
Leslie's
LESL
$63.8M
| $14.8K | ﹤0.01% |
+35,314
| New | +$14.8K |
|
2197
Aclaris Therapeutics
ACRS
$224M
| $14.5K | ﹤0.01% |
10,220
| – | – |
|
2198
Ring Energy
REI
$205M
| $13.6K | ﹤0.01% |
+17,107
| New | +$13.6K |
|
2199
Pyxis Oncology
PYXS
$99.8M
| $11K | ﹤0.01% |
+10,004
| New | +$11K |
|
2200
SmartRent
SMRT
$267M
| $10.6K | ﹤0.01% |
+10,706
| New | +$10.6K |
|